AVIFAVIR® is the first effective, registered drug for COVID‐19 treatment

In all of the excitement about Covid-19 Personal protective equipment (such as face masks, etc.) testing strategies, such as our CLINITEST COVID-19 rapid tests and Vaccines, little focus has been paid to Covid-19 treatments, which is astonishing, considering the fact that the first effective, registered drug for COVID-19 treatment, AVIFAVIR®, is ready to be delivered.


Several different types of potential vaccines for COVID-19 are on the market or in development, including:

  • Inactivated or weakened virus vaccines
  • Protein-based vaccines
  • Viral vector vaccines
  • RNA and DNA vaccines

To diagnose and contain the spread of coronavirus, testing is critical. There are these types- and quite a few brands of Covid-19 tests:

Usage of products to avoid the contagion with the COVID virus, such as:

  • Face masks
  • Hand sanitizer
  • Gloves
  • Etc.

AVIFAVIR® is an antiviral medication / drug, used to treat influenza, clinical studies have shown that AVIFAVIR enabled SARS-CoV-2 viral clearance and was safe and well-tolerated. When using AVIFAVIR®, patients:

  • Show rapid antiviral response (within 4 days in 62.5% of the cases)
  • Have shorter viral clearance time in patients with COVID-19
  • Have reduced mortality rates

Solarkiosk is the authorized distributor for AVIFAVIR®. AVIFAVIR® advantages:

  • Fully developed and scaled technology of API and DP manufacturing
  • High quality of the product: 2 years stability
  • Proprietary IP
  • Clinical study results showed the efficacy in COVID-19 treatmen
  • Fast supply of drug products to any destination
  • Competitive pricing

Report on summary of efficacy and safety post-marketing study of AVIFAVIR® in 940  patients with COVID-19 showed that the drug is efficient and save and has a number of positive impacts:

For COVID patients:

  • efficient and safe
  • Both in hospitals and at home
  • prevention of hospitalization
  • faster recovery
  • reduced contagion and isolation period

For Doctors

  • no fear of COVID-19
  • decreased burden on hospitals by 3 times
  • reduced hospitalization period by 30%

For the national economy

  • reduced social tensions
  • reduced disability period
  • support of economy
  • prevention of lockdown

Become a distribution partner

We are now looking for distribution partner of AVIFAVIR® is the first effective, registered drug for COVID‐19 treatment. Please contact us here for more information.